ProLectin‑M achieves 100% viral elimination by day seven in placebo‑controlled study
Category: News
Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million
Regulator recommends durvalumab as first perioperative IO option for muscle‑invasive disease
Re:Cognition Health and Cera collaborate to expand access to Alzheimer’s and neurodegenerative clinical trials
Oral candidate shows favourable safety profile and signs of clinical activity in NPDR
Recognising the achievements of this year’s standout healthcare collaborations
The company will initially develop a vaccine to tackle colorectal and pancreatic cancers
Perovial is the first ever hyaluronic acid injectable treatment to be licensed for acute Peyronie’s disease
The US sees around 476,000 new Lyme cases every year
Anaphylaxis is the most serious type of allergic reaction and occurs more commonly in boys